News
June 8, 2018—American Public Health Association (APHA) Organizations’ letter to U.S. Congress Appropriations Committee leaders in support of strong investments in antimicrobial resistance in FY 2019 appropriations bills using ONE HEALTH APPROACH SEE: https://goo.gl/kaai5a 3rd paragraph, “The report also highlights the need for continued and robust funding for AMR given that nationwide testing last year documented 221 cases of so-called “nightmare bacteria,” that can spread resistance to last-resort antibiotics. Robust, sustained investment in multi-agency One Health efforts is vital to combat AMR domestically and globally including prevention, antimicrobial stewardship, surveillance and data collection, research, and development of urgently needed new products including antimicrobial drugs, diagnostics, vaccines and alternative treatments.” 11th paragraph, “Food and Drug Administration and US Department of Agriculture Experts agree that a One Health approach, including both human and animal health, is essential for combating antimicrobial resistance. We urge funding of $54 million for the Combating Antibiotic Resistant Bacteria initiative at FDA to support FDA’s efforts to address public health concerns associated with antimicrobial drug use in animals, and better protect antibiotic effectiveness for both human and animal populations. This funding is needed now more than ever, with estimates that antibiotic use in humans and livestock will rise by 50% before 2030. FDA would be able to better collaborate with consumers, producers, veterinarians, and other agencies to monitor AMR through the National Antimicrobial Resistance Monitoring System (NARMS) as well as other initiatives by the FDA Center for Veterinary Medicine to address AMR.” Notably, see list of prominent organizational signatories: Accelerate Diagnostics, Inc. AdvaMedDx Alliance for Aging Research Alliance for the Prudent Use of Antibiotics American Academy of Pediatrics American Association of Avian Pathologists American Association of Bovine Practitioners American Public Health Association American Society of Transplant Surgeons American Society of Tropical Medicine & Hygiene American Thoracic Society American Veterinary Medical Association Antibiotic Resistance Action Center, the George Washington University Antimicrobials Working Group (Amplyx Pharmaceuticals, Aridis Pharmaceuticals, Arsanis Inc., Cidara Therapeutics Inc., ContraFect Corporation, Iterum Therapeutics Ltd., Melinta Therapeutics Inc., Motif Bio plc, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., SCYNEXIS Inc., Spero Therapeutics, Inc., T2 Biosystems Inc., Theravance Biopharma U.S. Inc., Viamet, Vical Incorporated, and Zavante Therapeutics Inc.) Association for Professionals in Infection Control and Epidemiology Association of American Veterinary Medical Colleges Association of State and Territorial Health Officials Becton Dickinson and Co. (BD) bioMerieux Biotechnology Innovation Organization (BIO) Center for Disease Dynamics, Economics & Policy Center for Foodborne Illness Research and Prevention Clinician Champions in Comprehensive Antibiotic Stewardship Consumer Federation of America Council of State and Territorial Epidemiologists Da Volterra Duke Center for Antimicrobial Stewardship and Infection Prevention Emory Antibiotic Resistance Center Food Animal Concerns Trust GlaxoSmithKline Global Health Council Health Care Without Harm HIV Medicine Association Immune Deficiency Foundation Infectious Diseases Society of America Johns Hopkins Center for a Livable Future Making-A-Difference in Infectious Diseases March of Dimes National Association of County and City Health Officials National Association of Pediatric Nurse Practitioners NovaDigm Therapeutics, Inc. Pediatric Infectious Diseases Society Peggy Lillis Foundation Sepsis Alliance Society of Critical Care Medicine Society of Infectious Diseases Pharmacists Spero Therapeutics The Fecal Transplant Foundation The Gerontological Society of America The Pew Charitable Trusts The Society for Healthcare Epidemiology of America The Society of Critical Care Medicine Treatment Action Group Trust for Americas Health
Quick Links
-
Please see MONOGRAPH in Veterinaria Italiana
“One Health – One Medicine”: linking human, animal and environmental health
Read More -
History of the One Health Initiative team and website (April 2006 through September 2015) and the One Health Initiative website since October 1, 2008 … revised to June 2020 and again to date February 2021
Read More -
Vaccines for zoonoses: a One Health paradigm
SciTech Europa Quarterly (March 2018) – Issue 26
Read More -
Pan European Networks SciTech Europa Quarterly
SciTech Europa Vaccines for zoonoses: a one Health paradigm – Pages 227-229 (Read PDF) “One of the One Health Initiative team’s co-founders and leaders is an internationally-recognized eminent physician…
Read More Read PDF